Work

Mp48-20 Outcomes of Patients With Refractory Oab Undergoing Percutaneous Tibial Nerve Stimulation in Real Life Practice

Year: 2020

Type: article

Abstract: CONCLUSIONS: Nearly 40% of patients continue BTX therapy beyond 5 years.Female gender and a diagnosis of nOAB are predictive of a patient preference for continued BTX treatment.

Source: The Journal of Urology

DOI: 10.1097/ju.0000000000000903.020

Authors: Wesley J. Smith*, Dayron Rodriguez, Alana L. Christie, Lauren Sudheimer, Maude E. Carmel, Gary E. Lemack, Philippe E. Zimmern

Language: English

Topic: Urinary Bladder and Prostate Research

Subfield: Urology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

OpenAlex ID: W3023669692

FWCI:

Cites:

Cited by:

Related to: 10